Analysis of vitamin D receptor levels in serum of leprosy patients of multibacillary type, erythema nodosum leprosum and normal people
DOI:
https://doi.org/10.66344/jpad.34.3.2024.2592Keywords:
Erythema Nodosum Leprosum, Leprosy, Vitamin D ReceptorAbstract
Objective Erythema Nodosum Leprosum (ENL) is an acute inflammatory reaction that occurs only in multibacillary (MB) leprosy patients. Serum Vitamin D Receptor (VDR) has been widely used as a biomarker to determine the progress of therapy in various diseases. This study aims to determine the difference between serum VDR in MB type leprosy patients who experience ENL reactions and those who do not experience ENL reactions and healthy people.  Methods The research was conducted using an analytic observational study with a cross sectional method. The total number of samples is 36 people, where each group consists of 12 people.  Results Mean serum VDR of multibacillary leprosy patients with an ENL reaction was 10.41 (4.34±18.12), whereas in the group without ENL it was 25.92 (23.32±29.42) and in the healthy group it was 39.51 (34.54±42.67).  Conclusion Based on statistical tests, it was found that serum VDR was significantly different between multibacillary leprosy patients who experienced ENL reactions and patients who did not experience ENL reactions and healthy people. ÂReferences
Ministry of Health of the Republic of Indonesia 2019. Decree of the Minister of Health of the Republic of Indonesia. Guidelines for Medical Services for Leprosy. 2019;8(5):55.
Salgado CG, Brito AC de, Salgado UI, Spencer JS. Fitzpatrik's Dermatology: Leprosy. 9th ed. Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. New York: Mc-Graw Hill Education; 2019. 2892–2919 p.
Kar HK, Chauhan A. IAL Textbook of Leprosy: Leprosy Reactions Pathogenesis and Clinical Features. 2nd ed. Kumar B, Kar HK, editors. IAL Textbook of Leprosy. New Delhi, India: the Health Sciences Publisher; 2017. 416–437 p.
Nobre ML, Illarramendi X, Dupnik KM, Hacker M de A, Nery JA da C, Jerônimo SMB, et al. Multibacillary leprosy by population groups in Brazil: Lessons from an observational study. PLoS Negl Trop Dis. 2017;11(2):1–14.
Polycarpou A, Walker SL, Lockwood DNJ. A systematic review of immunological studies of erythema nodosum leprosum. Immunol Front. 2017;8:233.
Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: Lessons learned from genome-wide analysis. Front Physiol. 2014;5:1–16.
Christakos S, Ajibade D V., Dhawan P, Fechner AJ, Mady LJ. Vitamin D: Metabolism. Endocrinol Metab Clin North Am. 2010;39(2):243–53.
Gupta V. Vitamin D: Extra-skeletal effects. J Med Nutr Neutraceutical. 2012;1:17–26.
Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the infection connection. Inflamm Res. 2014;63(10):803–19.
Hewison M. Vitamin D and immune function: Autocrine, paracrine or endocrine? Scand J Clin Lab Invest. 2012;72(suppl. 243):92-102.
Gombart AF, editor. Vitamin D: Oxidative Stress, Immunity, and Aging. Boca Raton: CRC Press; 2013. 462 p.
Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol. 2014;5:151.
Polycarpou A, Walker SL, Lockwood DNJ. A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum. Immunol Front. 2017;8:233.
Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take center stage. Nat Rev Immunol. 2008;8(9):685–98.
Karatay S, Yildirim K, Karakuzu A, Kiziltunc A, Engin RI, Eren YB, et al. Vitamin D status in patients with Behcet's Disease. Clinics. 2011;66(5):721–3.
Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502–21.
Mandal D, Reja AHH, Biswas N, Bhattacharyya P, Patra PK, Bhattacharya B. Vitamin D receptor expression levels determine the severity and complexity of disease progression among leprosy reaction patients. New Microbes New Infect. 2015;6:35–9.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.